Tissue plasminogen activator in saliva of hypertensives treated with angiotensin converting enzyme inhibitors or calcium antagonists.
Musumeci
V
V
Cattedra di Medicina Interna, CLOPD, Università Cattolica del S. Cuore, Rome, Italy.
Zappacosta
B
B
Zuppi
C
C
Bizzi
G
G
Di Salvo
S
S
Sacchi
A
A
Miani
C
C
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D004656:Enalapril / Q000627:therapeutic use; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000201:enzymology* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use; D012463:Saliva / Q000201:enzymology*; D010959:Tissue Plasminogen Activator / Q000378:metabolism*
D004656:Enalapril; D010959:Tissue Plasminogen Activator; D009543:Nifedipine